1. Home
  2. RGEN vs GATX Comparison

RGEN vs GATX Comparison

Compare RGEN & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • GATX
  • Stock Information
  • Founded
  • RGEN 1981
  • GATX 1898
  • Country
  • RGEN United States
  • GATX United States
  • Employees
  • RGEN N/A
  • GATX N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • GATX Transportation Services
  • Sector
  • RGEN Health Care
  • GATX Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • GATX Nasdaq
  • Market Cap
  • RGEN 6.6B
  • GATX 5.5B
  • IPO Year
  • RGEN N/A
  • GATX N/A
  • Fundamental
  • Price
  • RGEN $124.35
  • GATX $156.45
  • Analyst Decision
  • RGEN Buy
  • GATX Buy
  • Analyst Count
  • RGEN 9
  • GATX 2
  • Target Price
  • RGEN $167.38
  • GATX $172.50
  • AVG Volume (30 Days)
  • RGEN 1.0M
  • GATX 177.0K
  • Earning Date
  • RGEN 07-29-2025
  • GATX 07-29-2025
  • Dividend Yield
  • RGEN N/A
  • GATX 1.56%
  • EPS Growth
  • RGEN N/A
  • GATX 34.45
  • EPS
  • RGEN N/A
  • GATX 8.74
  • Revenue
  • RGEN $673,956,000.00
  • GATX $1,671,000,000.00
  • Revenue This Year
  • RGEN $14.14
  • GATX $10.94
  • Revenue Next Year
  • RGEN $14.32
  • GATX $5.40
  • P/E Ratio
  • RGEN N/A
  • GATX $17.84
  • Revenue Growth
  • RGEN 8.73
  • GATX 11.74
  • 52 Week Low
  • RGEN $102.97
  • GATX $127.70
  • 52 Week High
  • RGEN $182.52
  • GATX $168.89
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 54.96
  • GATX 54.94
  • Support Level
  • RGEN $111.15
  • GATX $154.87
  • Resistance Level
  • RGEN $127.57
  • GATX $161.24
  • Average True Range (ATR)
  • RGEN 4.80
  • GATX 3.16
  • MACD
  • RGEN 1.31
  • GATX 0.69
  • Stochastic Oscillator
  • RGEN 63.23
  • GATX 63.23

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About GATX GATX Corporation

GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.

Share on Social Networks: